Authors:
de Gast, GC
Klumpen, HJ
Vyth-Dreese, FA
Kersten, MJ
Verra, NCV
Sein, J
Batchelor, D
Nooijen, WJ
Schornagel, JH
Citation: Gc. De Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma, CLIN CANC R, 6(4), 2000, pp. 1267-1272
Citation: Gc. De Gast, Correspondence re: G. C. de Gast et al., phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6 : 1267-1272, 2000 - Reply, CLIN CANC R, 6(10), 2000, pp. 4167-4167
Authors:
van Dijk, AMC
Kessler, FL
Verdonck, LF
Stadhouders-Keet, SAE
van Lier, RAW
de Gast, GC
Otten, HG
Citation: Amc. Van Dijk et al., Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation, BR J HAEM, 111(3), 2000, pp. 791-796
Citation: G. Groenewegen et Gc. De Gast, GM-CSF can cause T cell activation; results of sequential chemo-immunotherapy, EUR J CANC, 35, 1999, pp. S23-S24
Authors:
van Dijk, AMC
Kessler, FL
Stadhouders-Keet, SAE
Verdonck, LF
de Gast, GC
Otten, HG
Citation: Amc. Van Dijk et al., Selective depletion of major and minor histocompatibility antigen reactiveT cells: towards prevention of acute graft-versus-host disease, BR J HAEM, 107(1), 1999, pp. 169-175
Authors:
Weimar, IS
Weijer, K
van den Berk, PCM
Muller, EJ
Miranda, N
Bakker, AQ
Heemskerk, MHM
Hekman, A
de Gast, GC
Gerritsen, WR
Citation: Is. Weimar et al., HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice, BR J CANC, 81(1), 1999, pp. 43-53